115 related articles for article (PubMed ID: 6724128)
1. Our experience with the use of buflomedil chlorhydrate in a mixed population of vasculopathic patients.
Battaglia L; Valgiusti D; Di Paola FM
J Int Med Res; 1984; 12(2):63-72. PubMed ID: 6724128
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
Montemurro NE; Damiano M
Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
[No Abstract] [Full Text] [Related]
3. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F
Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
[No Abstract] [Full Text] [Related]
4. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
[No Abstract] [Full Text] [Related]
5. [Study of carotid flow and cerebral circulatory impedance using Doppler computerized spectral analysis. Evaluation of the effect of buflomedil].
Scondotto G; De Fabritiis A; Caniato A; Pili C; Borgatti E
Minerva Cardioangiol; 1986 Nov; 34(11):751-8. PubMed ID: 3543731
[No Abstract] [Full Text] [Related]
6. [Buflomedil chlorhydrate in the treatment of retinopathies].
Spallone A; Porta E; Bertazzi E; Ridling P; Ortolina S; Fatigati G; Carlevaro G; Visentin E; Capilli G
Clin Ter; 1987 Apr; 121(2):125-8. PubMed ID: 2956000
[No Abstract] [Full Text] [Related]
7. [Use of buflomedil chlorhydrate in vertiginous patients. Vertigo].
Pianura CM; Di Lillo ML; Galati F; Massatani M; Mignano M
Minerva Cardioangiol; 1985 Jun; 33(6):369-72. PubMed ID: 4047427
[No Abstract] [Full Text] [Related]
8. [Buflomedil chlorhydrate in peripheral vasculopathies].
Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
[No Abstract] [Full Text] [Related]
9. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Clissold SP; Lynch S; Sorkin EM
Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
[TBL] [Abstract][Full Text] [Related]
10. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C
J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
Foray J; Baisse PE; Mont JP; Cahen C
Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
[TBL] [Abstract][Full Text] [Related]
12. Rheological activity of propionyl L-carnitine.
Pola P; Flore R; Tondi P; Nolfe G
Drugs Exp Clin Res; 1991; 17(3):191-6. PubMed ID: 1914846
[TBL] [Abstract][Full Text] [Related]
13. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil.
Jacobs MJ; Lemmens HA
Int J Microcirc Clin Exp; 1985; 4(1):63-8. PubMed ID: 3886577
[TBL] [Abstract][Full Text] [Related]
14. [Can the Doppler method indicate the usefulness of vasodilator therapy?].
Bartolo M; Antignani PL
Recenti Prog Med; 1981 Aug; 71(2):175-84. PubMed ID: 7313287
[No Abstract] [Full Text] [Related]
15. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
Paterna S; Martino S; Ingurgio NC; Arrostuto A; Correo S; Licata G
Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
[TBL] [Abstract][Full Text] [Related]
16. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
Marci M; Albiani B; Ricci M; Russo F
Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
[TBL] [Abstract][Full Text] [Related]
18. Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy.
Tsantilas D; Hatzitolios AI; Tziomalos K; Karamitsos D; Papadimitriou D
Int Angiol; 2011 Apr; 30(2):164-71. PubMed ID: 21427654
[TBL] [Abstract][Full Text] [Related]
19. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
[No Abstract] [Full Text] [Related]
20. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
